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thickness corneal disease in pediatric patients with healthy endothelium.
Methods: A retrospective analysis of pediatric patients who underwent mushroom keratoplasty.
The medical records of pediatric patients suffering from full thickness corneal stromal disease with
normal endothelium who underwent mushroom keratoplasty at our Institution were included. A
two-piece donor graft consisting of a large anterior stromal lamella (9.0 mm in diameter and
±250 lm in thickness) and a small posterior lamella (5–6.5 mm in diameter) including deep stroma
and endothelium, prepared with the aid of a microkeratome had been transplanted in all cases.
Ophthalmic examination including slit lamp examination, best corrected visual acuity, and corneal
topography was performed preoperatively and at each postoperative visit on all patients. The endo-
thelial cells were assessed by specular microscopy in these patients.
Results: Six eyes of six patients (ﬁve males and one female) were included. The mean age was
9.3 years (range 5–15 years). Average follow-up was 17.8 months (range 9–48 months).
There were no early or late complications recorded. All corneas were clear at the last follow up
visit.g of the American Society of
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270 M. Busin et al.Preoperative best corrected visual acuity (BCVA) was worse than 20/70 in all six eyes. Postoper-
atively, four eyes achieved BCVA of 20/40 or better.
Endothelial cell loss (n eyes = 3 averaged 24% (range 19–31%). The mean endothelial cell loss
was 24% (range 19–31%) among these patients.
Conclusions: Microkeratome assisted mushroom keratoplasty is a viable surgical option for pedi-
atric eyes with full thickness corneal stromal disease and healthy endothelium. Mushroom keratopl-
asty combines the refractive advantage of a large penetrating keratoplasty with the survival
advantage of a small penetrating keratoplasty. Furthermore, mushroom keratoplasty exhibits the
mechanical advantage of a shaped keratoplasty.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Acquired full-thickness corneal opacities in the pediatric pop-
ulation most commonly occur as sequelae of trauma or
microbial keratitis (Huang et al., 2009). Corneal endothelium
is frequently uninvolved, despite the full thickness stromal
disease. Deep anterior lamellar keratoplasty, by manual
(Melles et al., 1999) or big-bubble (Anwar and Teichmann,
2002) techniques, has been attempted for these eyes, however,
focal adhesions or gross breaches of the descemet membrane
(DM) render this procedure ineffective for many in this pa-
tient group. Newer techniques utilizing femtosecond laser
are inappropriate for these eyes, due to the inability of the la-
ser to function in the setting of signiﬁcant corneal opacity.
For these reasons, penetrating keratoplasty (PK) has, to date,
been the treatment of choice for these patients.
Long term survival of PK in the pediatric population is lim-
ited (Maguire et al., 1994). Contributing factors include the
hyperactive immune response leading to increased suture related
and rejection related complications and failure, as well as the
fact that these corneas are often vascularized (Epstein et al.,
1987; Ficker et al., 1988; Thomposon et al., 2003). In addition,
activities of children can be unpredictable, and traumaticwound
dehiscence is not uncommon following PK in this age group.
We know from the Collaborative Corneal Treatment Study
(CCTS) Maguire et al., 1994 and the more recent Corneal Do-
nor Study (CDS) Sugar et al., 2009, that neovascularized cor-
neas exhibit increased risk of rejection. In the past, small
diameter grafts have been attempted to treat full thickness cor-
neal disease in high risk cases such as those with corneal neo-
vascularization (Williams et al., 1992, 2008). Small diameter
grafts exhibit increased survival, however, astigmatism is high,
limiting visual rehabilitation (Williams et al., 1992, 2008), and
their use has, therefore, been discontinued. Large diameter
grafts have also been attempted, and do exhibit improved post-
operative astigmatism, although the chance of failure increases
as the size of the graft increases (Mader and Stulting, 1991;
Cowden et al., 1989).
We describe mushroom keratoplasty for the treatment of
full-thickness corneal opacity in the setting of healthy endothe-
lium in the pediatric population. This procedure involves
transplantation of a relatively small central area of the endo-
thelium and deep stroma, combined with transplantation of
a large anterior stromal lamellar. The resulting ‘‘mushroom’’
shaped two-piece graft combines the refractive advantages of
a large anterior lamellar keratoplasty, with the survival advan-
tage of a small PK (Busin and Arffa, 2005; Saelens et al.,
2008). A minimal amount of healthy host endothelium is
removed, however, the optical advantages of a PK are present.Importantly, this type of keratoplasty provides a stronger
wound proﬁle, not only preventing wound dehiscence in the
setting of minor trauma, but also allowing sutures to be re-
moved at an earlier date, reducing the chance of suture related
complications.
We present the results of an evaluation of mushroom kera-
toplasty performed in pediatric patients presenting to our insti-
tution with full thickness corneal stromal opacities in the
setting of otherwise healthy endothelium.2. Methods and materials
We reviewed the medical records of all patients of age
0–15 years inclusive that underwent mushroom keratoplasty
by the same surgeon (M.B.) at our institution from January
2006 to November 2010 inclusive.
Informed consent had been gained from all legally respon-
sible parents or guardians for the surgery performed. Analysis
of the data obtained was performed by means of a standard
spreadsheet program.
A complete ophthalmological examination had been
performed preoperatively. This included slit-lamp biomicros-
copy, best corrected visual acuity (BCVA), applanation
tonometry, ocular motility, and fundoscopy or B-scan of the
posterior segment. Visual acuity was measured by Snellen
chart in all patients. Corneal vascularization was evaluated
by slit-lamp examination and rated according to the extension
(number of clock hours involved) and depth (superﬁcial or
deep stroma). In addition, at all postoperative examination
times (12, 24, and 36 months) corneal topography analysis
(EyeSys 2000; EyeSys Technologies, Inc., Houston, Texas)
and endothelial cell count (cornea module of HRT-II Heidel-
berg Technology, Heidelberg, Germany) were performed.
Postoperative endothelial cell density (ECD) was evaluated
centrally, i.e., in the area of the posterior donor button; the
values recorded were compared with those obtained preopera-
tively from the eye bank, thus considering the cell loss as a per-
centage of the preoperative in vitro value, as described in a
previous paper from our group (Busin et al., 2008). Follow-
up examinations occurred at regular intervals, including but
not limited to day one, day two, week two, month one, month
three, month six, and then annually thereafter.3. Surgical technique
Patients all received general anesthesia, with the addition of
peribulbar injection of a 50% mixture of lidocaine 2%, and
bupivacaine 0.5%.
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o0clock position. The main surgical steps are illustrated in
Fig. 1. Mushroom keratoplasty was performed using our stan-
dard technique, as has been previously described (Busin and
Arffa, 2005). In brief, the host cornea was trephined to approx-
imately 200 lm in depth and 8.5 mm diameter using a suction
trephine (Hessburg Barron Trephine, Altomed, Tyne and
Wear, UK) centered in relation to the limbus. The anterior
lamellar was then removed by manual dissection, with a circu-
lar blade (MicroFeather circular blade, Feather Safety Razor
Co., Osaka, Japan).
The donor cornea was mounted on the artiﬁcial anterior
chamber of the automated lamellar therapeutic keratoplasty
system (ALTK; Moria SA, Antony, France); a 200-lm head
was used to split the donor cornea into anterior and posterior
lamellae. The anterior and posterior lamellae of the donor tis-
sue were then punched from the endothelial side to 8.5 and
6.0 mm, respectively (Barron Donor Corneal Punch, Altomed,
Tyne and Wear, UK). Next, a full-thickness trephination of
the remaining host cornea was performed, with a 6.0 mm suc-
tion trephine centered over the pupil. The host corneal button
was then completely removed using a corneal scissors. The
6.0 mm donor button, consisting of endothelium, DM, and
posterior stroma was then placed, over a small amount of vis-
coelastic, on the recipient bed. No sutures were used to attach
this posterior lamellar. The anterior donor lamellar, consisting
of epithelium and anterior stroma was then placed in position,
overlying the posterior donor button or ‘‘stem’’. The anterior
lamellar was sutured to the host cornea with a double contin-
uous 10–0 nylon suture. Finally, the anterior chamber was
ﬁlled with balanced salt solution, injected with a 30-gauge nee-
dle through a peripheral corneal tunnel.
All patients received topical tobramycin and dexametha-
sone (TobraDex, Alcon, Fort Worth Texas), two hourly by
day, tapered to once daily over a 6 month period. Patients with
corneal neovascularization, and, therefore, who were at in-
creased risk of immunologic rejection, also received systemic
steroids (Prednisolone 1 mg/kg tapered over 3 months). Sys-Figure 1 Surgical steps of mushroom keratoplasty. (A) Appearanc
depth. (B) Manual lamellar dissection. (C) Debulking completed wi
trephination, posterior button is removed with scissors. (E) Donor pos
placed and sutured in place.temic acyclovir (400 mg twice daily) was given for 1 year to
the patient with a history of herpetic keratitis.
In all cases, both sutures were removed within 9 months
from surgery. Patients 8 years old or younger had all sutures
removed by 6 months.
4. Results
Six eyes of six patients were included in this series. The average
age at surgery in the study was 9.3 years (range 5–15 years).
Five were males and one was female. Four eyes were phakic
and two aphakic prior to the transplant surgery.
Three corneal scars resulted from previous penetrating eye
injury, and two of these patientswere aphakic, and one had trau-
matic cataract at the time of transplantation. One eye had a his-
tory of herpetic keratitis, and one of bacterial keratitis. The
remaining patient had keratoconus with almost full thickness
corneal opacity. These three patients were phakic at the time
of transplantation, and remained so. Deep corneal vasculariza-
tion with at least 3 o0clock hours of involvement was present in
the two post infective cases.
Two patients had concurrent insertion of secondary poster-
ior chamber intraocular lens (IOL), and one patient underwent
combined phacoemulsiﬁcation and insertion of IOL. All pro-
cedures were uneventful. There were no episodes of graft rejec-
tion. No cases have developed cataract to date, and there have
been no additional early or late complications thus far. All
grafts remained clear at the ﬁnal examination. Figure 2. shows
an example of the postoperative appearance. Visual results are
summarized in Table 1.
At last follow-up (mean 17.8 months after surgery, range 9–
48 months), best spectacle corrected visual acuity (BSCVA) was
equal to or better than 20/40 in four of the six eyes. The mean
refractive cylinder was 4.50 Diopters (D) or less in ﬁve of six
cases, averaging 2.6 D. The endothelial cell loss, calculated from
the difference between eye bank data and endothelial cell den-
sity at last follow up, averaged 24% (range 19–31%), consider-
ing the three patients for which data was available.e post trephination, 9.0 mm diameter and approximately 250 lm
th corneal scissors. (D) After 6.5 mm central full thickness host
terior lamellar (6.5 mm) placed. (F) Anterior 9 mm donor lamellar
Figure 2 (A) Pre-operative appearance of a patient with healed full-thickness corneal wound following penetrating eye injury. (B) Post-
operative appearance of the same patient, 4 months following mushroom keratoplasty.
Table 1 Patient demographic data and visual results.
Patient Age/sex Diagnosis NV Lens status Surgery
combined with
Pre-op BSCVA
and refraction
Post-op BSCVA and
refraction
F/U ECL
MC 5/M PEI N A Secondary PCIOL 20/200 + 17/+3.0 · 30 20/50–2/4.5 · 50 11 N/A
ML 8/M PEI N P Phaco/IOL CF 20/400 9 N/A
AM 13/M Post MK Y P Nil CF 20/25–4.0/4.5 · 180 9 N/A
AP 8/M Post PEI N A Secondary PCIOL 20/70 + 10 20/22.5–2.5/2.5 · 40 18 22
VSR 7/F Post HSK Y P Nil 20/200 20/22.5–2.0/81.0 · 175 48 31
MS 15/M KCN N P Nil 20/200 20/22.5 0/0.5 · 155 12 19
Abbreviations: M=male, F = female, NV= neovascularization, N = no, Y = yes, A = aphakic, P = phakic, PCIOL= posterior chamber
intraocular lens, Phaco = phacoemulsiﬁcation, Pre-op = preoperative, BSCVA= best spectacle corrected visual acuity, F/U= follow-up,
ECL= endothelial cell loss, N/A = not available.
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Penetrating keratoplasty in children is a high risk procedure
(Maguire et al., 1994; Epstein et al., 1987; Ficker et al., 1988;
Thomposon et al., 2003; Al-Ghamdi et al., 2007). Increased
surgical difﬁculties, as well as the unpredictable postoperative
course results in an increased rate of graft failure for these pa-
tients, and parents are usually counseled regarding at best a
moderate prognosis (Al-Ghamdi et al., 2007).
Most cases of PK failure in children with acquired corneal
opacities occur relatively early in the post-operative period
(Al-Ghamdi et al., 2007; Ehrich et al., 1991; Stulting et al.,
1984). Ehrich et al. report most failures in the ﬁrst 6 months,
(Ehrich et al., 1991) whilst Stulting et al. report most failures
in this group occurring in the ﬁrst 12 months (Stulting et al.,
1984). Al-Ghamdi et al. reported that 65.2% of graft failures
in the pediatric age had occurred by the end of the ﬁrst year,
and 88% by the end of the second year (Al-Ghamdi et al.,
2007).
In addition to the young age, corneal neovascularization is
a common ﬁnding in acquired full-thickness corneal disease.
Corneal neovascularization is known to be one of the main
risk factors for the development of post-PK endothelial rejec-
tion and consequent graft failure (Maguire et al., 1994; Sugar
et al., 2009). This is particularly true when deep stromal vascu-
larization exceeds 3 o0clock hours in extension, as it is often the
case in eyes with post-infectious scars of various origins
(Thomposon et al., 2003; Price et al., 1993; Dandona et al.,
1997; Vail et al., 1994). In these eyes, full-thickness grafts ofsmall diameter have shown higher long-term survival rates
than those of conventional size (7.0–8.0 mm), but their use
has been discontinued due to the unacceptably high degree
of astigmatism (Williams et al., 1992, 2008).
The increased survival of small PKs may be due to the lower
antigenic load or the greater distance from the vascular supply
at the limbus, and resultant lower frequency of rejection epi-
sodes (Mader and Stulting, 1991). A further explanation could
relate to previous evidence showing that endothelial cells mi-
grate across the graft-host junction of a PK, from areas of high
endothelial cell density, to areas of lower density (Imaizumi,
1990; Groh et al., 1999; Langenbucher et al., 2002). This may
occur from the graft to the host, in eyes with endothelial disease
such as Fuchs’ endothelial dystrophy, or may occur from the
host to the graft in cases with healthy host endothelium, such
as those described herein. As we are transplanting only a min-
imal amount of host endothelium (approximately 25%), it is
theoretically possible for the healthy host endothelial cells to
repopulate the small diameter posterior button following an
irreversible episode of graft rejection in these patients
(Imaizumi, 1990; Groh et al., 1999; Langenbucher et al.,
2002). Rearrangement of endothelial cells between the donor
and recipient may provide explanation for the 100% graft sur-
vival in this study.
Deep Anterior Lamellar Keratoplasty (DALK) is fre-
quently not effective for the treatment of full-thickness corneal
disease. This is due to the gross disruption of the full corneal
thickness following PEI, and the often present adhesions
between DM and corneal stroma following microbial keratitis.
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few surgeons are able to overcome (Fontana et al., 2007;
Sarnicola and Toro, 2010). For these reasons, manual or big-
bubble DALK are often complicated by perforation of DM
in these cases. Femtosecond laser is also not an option, as
the corneal opacity would be expected to hinder the penetra-
tion of the LASER.
Ebeling and Carrel developed and performed the ﬁrst
mushroom shaped penetrating keratoplasty in 1921 (Ebeling
and Carrel, 1921). This was before the advent of the operating
microscope. In the setting of the obvious technical difﬁculties,
the procedure did not gain popularity at that time. Much more
recently, shaped keratoplasties have gained increasing popu-
larity, in large part due to the stronger wound proﬁle and im-
proved visual outcome (Francheschetti, 1951; Busin, 2003;
Bahar et al., 2008). Mushroom keratoplasty provides a shaped
wound edge, much less likely to dehisce in the event of minor
trauma. Wound dehiscence is a lifelong concern following PK
in the pediatric population, especially whilst the patients are
young and their activities unpredictable.
With the use of the microkeratome, we have revisited the
idea of mushroom keratoplasty. This two-piece donor graft
provides the advantage of centration of the posterior ‘‘stem’’
of the graft on the pupil, whilst being able to center the ante-
rior ‘‘hat’’ on the limbus. This is important for optimal visual
outcome in the setting of the relatively small posterior graft.
The posterior lamellar maintains its position without the need
for sutures, similar to deep lamellar endothelial keratoplasty
(DLEK) (Melles et al., 1998). The interface created by two
microkeratome dissected surfaces is negligible, as demon-
strated by laser in situ keratomileusis (LASIK), and also by
other types of anterior and posterior microkeratome-assisted
lamellar surgery. Good vision is the rule rather than the excep-
tion in patients undergoing these procedures (Busin et al.,
2005; Chen et al., 2008; Shortt et al., 2006).
In conclusion, mushroom keratoplasty provides the optical
beneﬁts of a PK, with the wound stability and increased survival
of a lamellar keratoplasty. The refractive advantage of a large
graft is present, in addition to the increased survival of a small
graft. Most of the recipient endothelium is preserved, providing
the opportunity for reorganization of the host endothelium
across the graft host junction in the event of a rejection episode.
Visual and refractive results of mushroom keratoplasty in chil-
dren compare favorably with those of conventional PK, at least
in the medium term. Further studies would be required to ade-
quately assess the long-term survival of these grafts.
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